Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,466 | -35,952 | -24,491 | -466,456 | -267,509 |
| Depreciation Amortization | 34,670 | 27,936 | 14,326 | 42,471 | 25,139 |
| Income taxes - deferred | 630 | 630 | 630 | 404 | 408 |
| Accounts receivable | 26,328 | 28,828 | -12,547 | -18,816 | -2,229 |
| Other Working Capital | -29,569 | -28,427 | -40,814 | 6,365 | 21,882 |
| Other Operating Activity | -7,356 | -36,457 | 16,287 | 310,336 | 116,578 |
| Operating Cash Flow | $-6,763 | $-43,442 | $-46,609 | $-125,696 | $-105,731 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,088 | 10,390 | -12,090 | 83,506 | 70,506 |
| PPE Investments | 4,445 | 19,276 | 1,372 | -2,544 | -2,098 |
| Other Investing Activity | 0 | 0 | 0 | -60,000 | -60,000 |
| Investing Cash Flow | $-7,643 | $29,666 | $-10,718 | $20,962 | $8,408 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | 0 | -21,417 | -21,417 |
| Common Stock Issued | 798 | 631 | 0 | 1,536 | 881 |
| Common Stock Repurchased | 0 | 0 | 0 | -13,730 | -13,730 |
| Other Financing Activity | -1,417 | -1,343 | -1,227 | -1,902 | -1,867 |
| Financing Cash Flow | $-619 | $-712 | $-1,227 | $-35,513 | $-36,133 |
| Beginning Cash Position | 113,504 | 113,504 | 113,504 | 253,751 | 253,751 |
| End Cash Position | 98,479 | 99,016 | 54,950 | 113,504 | 120,295 |
| Net Cash Flow | $-15,025 | $-14,488 | $-58,554 | $-140,247 | $-133,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,763 | -43,442 | -46,609 | -125,696 | -105,731 |
| Capital Expenditure | -475 | -68 | -68 | -2,544 | -2,098 |
| Free Cash Flow | -7,238 | -43,510 | -46,677 | -128,240 | -107,829 |